FDA Approves New Bivalent COVID-19 Booster for Use in Children
Moderna vaccine is authorized for children down to 6 years old, while Pfizer-BioNTech vaccine is approved for children as young as 5 years
FDA Approves Boostrix for Third-Trimester Administration
Approval is specifically for use during pregnancy to prevent pertussis in infants whose mothers are vaccinated during pregnancy
Risk for Type 1 Diabetes in Children May Rise After COVID-19
Increased risk persists for up to six months postinfection for pediatric patients aged 0 to 18 years
Patient Care Delayed at Large Hospital Chain After Ransomware Attack
Attack on CommonSpirit Health, the fourth-largest U.S. health system, led to delays in surgeries, patient care, and appointments
Early Steroid Use Does Not Cut Hospital Stay for Non-MIS-C COVID-19
Early use of steroids in children hospitalized for COVID-19 without MIS-C not associated with shorter length of stay
Cefepime/Enmetazobactam Noninferior for Complicated UTI
Cefepime/enmetazobactam is noninferior and superior to piperacillin/tazobactam for clinical cure and microbial eradication
Safe Sex Texts Do Not Cut Sexually Transmitted Disease Reinfection Rates
Findings seen among young adults randomly assigned to receive regular texts
CDC Will Stop Issuing Daily Updates of COVID-19 Cases, Deaths
Move is in line with efforts to wind down other COVID-19-related tools on the CDC website
U.S. to Screen Travelers From Uganda for Ebola Amid Outbreak in That Country
Screenings will include a temperature check and a health questionnaire to be shared with local officials
Patient Belief About Success of Antibiotics Tied to Appendicitis Outcomes
Beliefs about likely success of antibiotic therapy linked to lower risk for appendectomy, resolution of signs and symptoms by 30 days
